It’s GlycoEra’s time to shine. The biotech has closed a series B fundraise clocking in at $130 million, with the funds set to ...

The startup is the latest beneficiary of investors’ appetite for protein-degrading technology, which offers a way to reach ...

RevivBio, a trailblazing biotech company Redefining Biologics and Biosensors development, welcomes Dr. Ron Meeusen to its Board of Directors. Dr. Meeusen is a renowned leader in biotechnology, with a ...

Cvictus recently received a $1.7 million grant from the Bill & Melinda Gates Foundation to scale its technology.

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

Backed by major investors, Volare’s new facility will turn food waste into sustainable insect protein and help boost Europe’s ...

AbbVie (NYSE: ABBV) in partnership with the University of Toronto's SpinUp, are pleased to announce Neuropeutics Inc as the ...

Cambridge biotech Nuclera has agreed a collaboration with Danaher company and international life sciences leader Cytiva – ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

At the recent F&A Next conference in Wageningen, the Feike Sijbesma Sustainable Innovation Award 2025 was granted to two ...

Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, T2D and other metabolic diseases.